Evidence map›Paper›PMID 42941738›Full record

ReviewInternational journal of molecular sciences2026

Recent Advances in Synthetic Strategies and Medicinal Properties of Thienopyridines.

Anfisa Ermolaeva, Svetlana Baykova, Sergey Baykov, Roman Ivanov, Ekaterina Minskaia

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anfisa ErmolaevaTranslational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave., 1, Sirius 354340, Russia.ORCID 0000-0002-9994-9798
Svetlana BaykovaTranslational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave., 1, Sirius 354340, Russia.ORCID 0000-0002-7943-7525
Sergey BaykovTranslational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave., 1, Sirius 354340, Russia.ORCID 0000-0002-8912-5816
Roman IvanovTranslational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave., 1, Sirius 354340, Russia.ORCID 0000-0002-9573-4183
Ekaterina MinskaiaTranslational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave., 1, Sirius 354340, Russia.ORCID 0000-0002-1137-373X

Funding

Administration of "Sirius" Federal Territory Agreement 560 No. 20-03 on 01 June 2026
6 · The paper itself

Abstract

This review provides an updated overview of recent advances (2024-present) in the synthesis and medicinal applications of thienopyridines and their fused derivatives. Synthetic methodologies are categorized into three strategic approaches: (i) thiophene ring construction onto a preformed pyridine core; (ii) pyridine ring annulation onto a thiophene scaffold-ranging from classical Friedländer and Gould-Jacobs reactions to modern metal-catalyzed, photo-induced, and electrochemical transformations; and (iii) multicomponent reactions for the simultaneous assembly of both heterocyclic rings. Furthermore, the strategic functionalization of preformed thienopyridine scaffolds to access complex tri- and polyheterocyclic systems is discussed. From a biological perspective, the review highlights the scaffold's expanding therapeutic repertoire, including antibacterial, antifungal, and antiviral activities; potent anticancer applications targeting tumor-associated enzymes and emerging Proteolysis Targeting Chimera (PROTAC)/Deubiquitinase-Targeting Chimera (DUBTAC) technologies; and modulation of neurological, neuropsychiatric, and metabolic disorders. Finally, recent progress in the agrochemical utility of thienopyridines as insecticides and herbicide safeners is examined. Collectively, this work underscores the enduring relevance of the thienopyridine scaffold as a versatile platform for next-generation drug and agrochemical discovery.

Indexed as

PyridinesThienopyridinesAnimalsAntineoplastic AgentsDrug DiscoveryHumansProteolysis Targeting ChimeraAntineoplastic AgentsProteolysis Targeting ChimeraPyridinesThienopyridinesagrochemistrycondensationcyclizationdrug discoveryheterocyclesmedicinal chemistry

Identifiers

PMID42941738
PMCPMC13704120

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.